缩写名/全名 |
J PHARM PHARMACOL
JOURNAL OF PHARMACY AND PHARMACOLOGY |
||||||||||||||||||||
ISSN号 | 0022-3573 | ||||||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||||||
影响因子 | 2015:2.363, 2016:2.405, 2017:2.309, 2018:2.39, 2019:2.571, | ||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||
年文章数 | 160 | ||||||||||||||||||||
出版年份 | 1949 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均3.0个月 |
||||||||||||||||||||
录用比例 | 约75% | ||||||||||||||||||||
投稿链接 | http://mc.manuscriptcentral.com/jppharm | ||||||||||||||||||||
投稿官网 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)2042-7158 | ||||||||||||||||||||
h-index | 107 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-3573%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Neuroprotective effect of mogrol against Aβ1-42 -induced memory impairment neuroinflammation and apoptosis in mice. Author: Chen G1, Liu C2, Meng G3, Zhang C2, Chen F2, Tang S2, Hong H2, Zhang C4. Journal: J Pharm Pharmacol. 2019 May;71(5):869-877. doi: 10.1111/jphp.13056. Epub 2018 Dec 26. PubMed DOI |
2. | Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer. Author: Du J1,2, He Y3, Wu W1,2, Li P1,2, Chen Y1,2, Hu Z2,4,5, Han Y2,5,6. Journal: J Pharm Pharmacol. 2019 Feb;71(2):196-205. doi: 10.1111/jphp.12941. Epub 2019 Jan 2. PubMed DOI |
3. | Minimally modified low-density lipoprotein upregulates the ETB and α1 receptors in mouse mesenteric arteries in vivo by activating the PI3K/Akt pathway. Author: Zeng ZS1, Lin J1, Xu CB2, Cao L3, Chen C1, Li J1. Journal: J Pharm Pharmacol. 2019 Jun;71(6):937-944. doi: 10.1111/jphp.13069. Epub 2019 Jan 20. PubMed DOI |
4. | Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats. Author: Tian X1,2, Chang Y1,2, Wei J1,2, Liu R1,2, Wang L3, Zhang J1,2, Zhang X1,2. Journal: J Pharm Pharmacol. 2019 May;71(5):788-796. doi: 10.1111/jphp.13067. Epub 2019 Jan 21. PubMed DOI |
5. | LncRNA TapSAKI promotes inflammation injury in HK-2 cells and urine derived sepsis-induced kidney injury. Author: Shen J1, Liu L2, Zhang F3, Gu J3, Pan G1. Journal: J Pharm Pharmacol. 2019 May;71(5):839-848. doi: 10.1111/jphp.13049. Epub 2019 Jan 21. PubMed DOI |
6. | The preparation and investigation of spinosin-phospholipid complex self-microemulsifying drug delivery system based on the absorption characteristics of spinosin. Author: Song P1, Lai C2, Xie J1,3, Zhang Y1,3. Journal: J Pharm Pharmacol. 2019 Jun;71(6):898-909. doi: 10.1111/jphp.13076. Epub 2019 Feb 19. PubMed DOI |
7. | Endothelin-1 increases CHSY-1 expression in aortic endothelial cells via transactivation of transforming growth factor β type I receptor induced by type B receptor endothelin-1. Author: Seif F1, Little PJ2,3, Niayesh-Mehr R1, Zamanpour M1, Babaahmadi-Rezaei H1. Journal: J Pharm Pharmacol. 2019 Jun;71(6):988-995. doi: 10.1111/jphp.13081. Epub 2019 Feb 27. PubMed DOI |
8. | Synthesis, cytotoxicity and liver targeting of 3-O-β-D-Galactosylated Resveratrol. Author: Qian J1,2, Zha L1,2, Wang B1,2, Zhang C1,2, Hong L1,2, Chen W1,2. Journal: J Pharm Pharmacol. 2019 Jun;71(6):929-936. doi: 10.1111/jphp.13084. Epub 2019 Mar 4. PubMed DOI |
9. | Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway. Author: Jia L1, Sun P1, Gao H1, Shen J1, Gao Y1, Meng C1, Fu S1, Yao H1, Zhang G2. Journal: J Pharm Pharmacol. 2019 Jun;71(6):1017-1028. doi: 10.1111/jphp.13077. Epub 2019 Mar 7. PubMed DOI |
10. | Tanshinone IIA protects against lipopolysaccharide-induced lung injury through targeting Sirt1. Author: Quan M1, Lv Y2, Dai Y1, Qi B3, Fu L2, Chen X2, Qian Y1. Journal: J Pharm Pharmacol. 2019 Mar 13. doi: 10.1111/jphp.13087. [Epub ahead of print] PubMed DOI |
|
|